Home NDC 70121-2630-2 Ketamine hydrochloride
Product NDC 70121-2630
Requested package NDC 70121-2630-2
11-digit product format 701212630
Labeler code 70121
Product ID 70121-2630_55b66c25-8d9f-4f7b-abff-80b903aa29ae
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ketamine hydrochloride
Dosage form INJECTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Amneal Pharmaceuticals LLC
Application ANDA220380
Marketing category ANDA
Marketing start 2026-11-16
Substance KETAMINE HYDROCHLORIDE
Active strength 10 mg/mL
Pharmacologic classes General Anesthesia [PE], General Anesthetic [EPC]
DEA schedule CIII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A220380-001 KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS AP 2026-11-04 A220380-002 KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE EQ 50MG BASE/ML (EQ 50MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RS 2026-11-04
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A220380-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A220380-001 KETAMINE HYDROCHLORIDE EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS AP 2026-11-04 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A220380-002 KETAMINE HYDROCHLORIDE EQ 50MG BASE/ML (EQ 50MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RS 2026-11-04 d4dbc9d85df4…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-11-14 07:37:17 2026-10 A220380-001 AP 1 d4dbc9d85df4…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Ketamine hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength KETAMINE HYDROCHLORIDE 10 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination O18YUO0I83 Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 70121-2630-2 70121263002 24 SYRINGE, GLASS in 1 CARTON (70121-2630-2) / 5 mL in 1 SYRINGE, GLASS 2026-11-16 No No Current